1 Until Article 16 paragraph 5 enters into force, the notification obligation for manufacturers domiciled in Switzerland according to Article 6 paragraphs 2 and 4 MedDO73 in the version dated 26 November 201774 continue to apply.
2 ...75
3 The notification obligation according to Article 10 for devices manufactured and used in healthcare institutions applies from the following dates:
This document is not an official publication. Only the publication of the Federal Chancellery is legally binding.
Dies ist keine amtliche Veröffentlichung. Massgebend ist allein die Veröffentlichung durch die Bundeskanzlei.